Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22948 | 307 | 24.4 | 42% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
232 | 19686 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CENTCHROMAN | Author keyword | 24 | 67% | 7% | 22 |
2 | DL111 IT | Author keyword | 23 | 100% | 3% | 10 |
3 | ORMELOXIFENE | Author keyword | 12 | 59% | 4% | 13 |
4 | ST1959 | Author keyword | 6 | 80% | 1% | 4 |
5 | TCCU | Address | 6 | 100% | 1% | 4 |
6 | 7 DESMETHYL CENTCHROMAN | Author keyword | 3 | 100% | 1% | 3 |
7 | D CENTCHROMAN | Author keyword | 3 | 100% | 1% | 3 |
8 | L CENTCHROMAN | Author keyword | 3 | 100% | 1% | 3 |
9 | ANTI IMPLANTATION AGENTS | Author keyword | 2 | 67% | 1% | 2 |
10 | ESTROGEN AGONISTS | Author keyword | 2 | 43% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CENTCHROMAN | 24 | 67% | 7% | 22 | Search CENTCHROMAN | Search CENTCHROMAN |
2 | DL111 IT | 23 | 100% | 3% | 10 | Search DL111+IT | Search DL111+IT |
3 | ORMELOXIFENE | 12 | 59% | 4% | 13 | Search ORMELOXIFENE | Search ORMELOXIFENE |
4 | ST1959 | 6 | 80% | 1% | 4 | Search ST1959 | Search ST1959 |
5 | 7 DESMETHYL CENTCHROMAN | 3 | 100% | 1% | 3 | Search 7+DESMETHYL+CENTCHROMAN | Search 7+DESMETHYL+CENTCHROMAN |
6 | D CENTCHROMAN | 3 | 100% | 1% | 3 | Search D+CENTCHROMAN | Search D+CENTCHROMAN |
7 | L CENTCHROMAN | 3 | 100% | 1% | 3 | Search L+CENTCHROMAN | Search L+CENTCHROMAN |
8 | ANTI IMPLANTATION AGENTS | 2 | 67% | 1% | 2 | Search ANTI+IMPLANTATION+AGENTS | Search ANTI+IMPLANTATION+AGENTS |
9 | ESTROGEN AGONISTS | 2 | 43% | 1% | 3 | Search ESTROGEN+AGONISTS | Search ESTROGEN+AGONISTS |
10 | 2 4 N PROPYLBENZENEIMIDAZOLE2 1 AISOQUINOLINE | 1 | 100% | 1% | 2 | Search 2+4++N+PROPYLBENZENEIMIDAZOLE2+1+AISOQUINOLINE | Search 2+4++N+PROPYLBENZENEIMIDAZOLE2+1+AISOQUINOLINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CENTCHROMAN | 25 | 73% | 6% | 19 |
2 | NIDATORY ESTROGEN | 15 | 88% | 2% | 7 |
3 | PINOPOD DEVELOPMENT | 6 | 100% | 1% | 4 |
4 | STEROIDAL CONTRACEPTIVE DEVELOPMENT | 6 | 100% | 1% | 4 |
5 | ENDOMETRIAL SENSITIVITY | 5 | 60% | 2% | 6 |
6 | TRIPHENYLETHYLENE ANTIESTROGEN | 4 | 67% | 1% | 4 |
7 | ANTIIMPLANTATION AGENT | 3 | 100% | 1% | 3 |
8 | CDRI 85 287 | 3 | 100% | 1% | 3 |
9 | BIOLOGICAL PROFILE | 3 | 28% | 3% | 10 |
10 | ANTI FERTILITY AGENTS | 2 | 67% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Centchroman, a selection estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders | 2001 | 55 | 62 | 77% |
Clinical pharmacokinetics and interaction of centchroman - A mini review | 2010 | 12 | 30 | 87% |
The potent triaryiethylene pharmacophore | 2004 | 12 | 100 | 21% |
NONSTEROIDAL ANTIFERTILITY AGENTS | 1993 | 1 | 138 | 20% |
EFFECTS OF DRUGS ON THE EPIDIDYMIS | 1982 | 2 | 2 | 100% |
DEVELOPMENT OF MALE-FERTILITY-REGULATING AGENTS | 1991 | 3 | 47 | 6% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TCCU | 6 | 100% | 1.3% | 4 |
2 | TISSUE CULTURE ANIM | 1 | 100% | 0.7% | 2 |
3 | PLOUGH STERILE DRUG DELIVERY SYST | 1 | 50% | 0.3% | 1 |
4 | CSIR CENT DRUG | 0 | 33% | 0.3% | 1 |
5 | CHEM BIOL PHARMACOL | 0 | 25% | 0.3% | 1 |
6 | NURSE PRACTITIONER | 0 | 20% | 0.3% | 1 |
7 | TRANSPLANT CHIARA CUCCHI ALESSANDRI GIL | 0 | 11% | 0.3% | 1 |
8 | ALTANTA MED | 0 | 100% | 0.3% | 1 |
9 | TISSUE CELL CULTURE UNIT TCCU | 0 | 100% | 0.3% | 1 |
10 | ZJU ENS JIONT MED CHEM | 0 | 100% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000149882 | 2 ACETYLESTRADIOL 17 BETA ACETATE//UTEROTROPHIC ACTIVITY//AERIAL OXIDATIVE CYCLIZATION |
2 | 0.0000125022 | SERAMS//MATH CHEM//ESTROGEN RECEPTOR LIGANDS |
3 | 0.0000111558 | AEBS//ANTIESTROGEN BINDING SITES//ANALOG II |
4 | 0.0000105575 | BIOL REPROD EXTRACELLULAR MATRIX//REPROD EXTRACELLULAR MATRIX BIOL//BIOMED SCI HISTOL EMBRYOL |
5 | 0.0000091656 | FSH AND PMSG SUPEROVULATION//PINEAL N ACETYLTRANSFERASE ACTIVITY//EMINENTIA MEDIANA |
6 | 0.0000088383 | EXPT ENDOCRINOL ENVIRONM PATHOL//ENVIRONM BIOMED CIMAB//EXPT ENDOCRINOL ENVIRONM PATHOL LEEPA |
7 | 0.0000081164 | RING TRANSFORMATION REACTION//2H PYRAN 2 ONE//2H PYRAN 2 ONES |
8 | 0.0000073392 | TYPE I IODOTHYRONINE 5 MONODEIODINASE//IODOTHYRONINE 5 MONODEIODINASE//TYPE I IODOTHYRONINE 5 MONODEIODINASE |
9 | 0.0000069936 | INO 2628 CZ//DOUBLE PEAKS//DISCONTINUOUS ABSORPTION |
10 | 0.0000068720 | CD 832//KT 362//HEART RATE DEPENDENCY |